Professional Documents
Culture Documents
certain beans, nuts, seeds and vegetables with pasta and rice (2-
also contributing to choline intake in the American diet.[4][7] Hydroxyethyl)trimethylammonium
Identifiers
CAS Number 62-49-7 (https://com
Contents monchemistry.cas.or
g/detail?cas_rn=62-4
Chemistry
9-7) choline
Metabolism hydroxide
Biosynthesis
Absorption 3D model Interactive image (htt
(JSmol) ps://chemapps.stolaf.
Transport
Storage edu/jmol/jmol.php?m
Excretion odel=C%5BN%2B%5
D%28C%29%28C%2
Function 9CCO)
Phospholipid precursor
Acetylcholine synthesis Beilstein 1736748
Reference
Source of trimethylglycine
ChEBI CHEBI:15354 (http
Content in foods
s://www.ebi.ac.uk/che
Daily values
Dietary recommendations bi/searchId.do?chebiI
Intake in populations d=15354)
Choline chloride can be made by treating TMA with 2- PubChem CID 305 (https://pubche
chloroethanol:[1] m.ncbi.nlm.nih.gov/c
ompound/305)
(CH3)3N + ClCH2CH2OH → (CH3)3N+ CH2CH2OH
UNII N91BDP6H0X (http
· Cl–
s://fdasis.nlm.nih.gov/
The 2-chloroethanol can be generated from ethylene oxide. srs/srsdirect.jsp?regn
Choline has historically been produced from natural sources, o=N91BDP6H0X)
such as via hydrolysis of lecithin.[1] CompTox DTXSID8043789 (htt
Dashboard ps://comptox.epa.go
Metabolism (EPA)
v/dashboard/chemica
l/details/DTXSID8043
789)
Biosynthesis
InChI
In plants, the first step in de novo biosynthesis of choline is the InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7
decarboxylation of serine into ethanolamine, which is catalyzed H,4-5H2,1-3H3/q+1
by a serine decarboxylase.[10] The synthesis of choline from Key: OEYIOHPDSNJKLS-UHFFFAOY
ethanolamine may take place in three parallel pathways, where SA-N
three consecutive N-methylation steps catalyzed by a methyl SMILES
transferase are carried out on either the free-base,[11] phospho-
C[N+](C)(C)CCO
bases,[12] or phosphatidyl-bases.[13] The source of the methyl
group is S-adenosyl-l-methionine and S-adenosyl-l- Properties
homocysteine is generated as a side product.[14] Chemical C5H14NO+
formula
In humans and most other animals, de novo synthesis of choline
is via the phosphatidylethanolamine N-methyltransferase Molar mass 104.17 g/mol
(PEMT) pathway,[6] but biosynthesis is not enough to meet Appearance viscous deliquescent
human requirements.[15] In the hepatic PEMT route, 3- liquid (choline
phosphoglycerate (3PG) receives 2 acyl groups from acyl-CoA hydroxide)[1]
forming a phosphatidic acid. It reacts with cytidine triphosphate Solubility in very soluble (choline
to form cytidine diphosphate-diacylglycerol. Its hydroxyl group water hydroxide)[1]
reacts with serine to form phosphatidylserine which
decarboxylates to ethanolamine and phosphatidylethanolamine Solubility soluble in ethanol,[1]
(PE) forms. A PEMT enzyme moves three methyl groups from insoluble in
three S-adenosyl methionines (SAM) donors to the diethylether and
ethanolamine group of the phosphatidylethanolamine to form chloroform (choline
choline in the form of a phosphatidylcholine. Three S- hydroxide)[2]
adenosylhomocysteines (SAHs) are formed as a byproduct.[6]
Hazards
Choline can also be released from more complex choline GHS labelling:
containing molecules. For example, phosphatidylcholines (PC)
Pictograms
can be hydrolyzed to choline (Chol) in most cell types. Choline
can also be produced by the CDP-choline route, cytosolic
choline kinases (CK) phosphorylate choline with ATP to Signal word Danger
phosphocholine (PChol).[2] This happens in some cell types like
liver and kidney. Choline-phosphate cytidylyltransferases Hazard H314
statements
(CPCT) transform PChol to CDP-choline (CDP-Chol) with
cytidine triphosphate (CTP). CDP-choline and diglyceride are Precautionary P260, P264, P280,
transformed to PC by diacylglycerol cholinephosphotransferase statements P301+P330+P331,
(CPT).[6] P303+P361+P353,
P304+P340,
In humans, certain PEMT-enzyme mutations and estrogen P305+P351+P338,
deficiency (often due to menopause) increase the dietary need P310, P321, P363,
for choline. In rodents, 70% of phosphatidylcholines are formed
P405, P501
via the PEMT route and only 30% via the CDP-choline
route.[6] In knockout mice, PEMT inactivation makes them NFPA 704
completely dependent on dietary choline.[2] (fire diamond)
COR
Absorption
Lethal dose or concentration (LD,
In humans, choline is absorbed from the intestines via the LC):
SLC44A1 (CTL1) membrane protein via facilitated diffusion LD50 (median 3–6 g/kg bw, rats,
governed by the choline concentration gradient and the dose) oral[1]
electrical potential across the enterocyte membranes. SLC44A1
Safety data 4
has limited ability to transport choline: at high concentrations
part of it is left unabsorbed. Absorbed choline leaves the sheet (SDS)
enterocytes via the portal vein, passes the liver and enters Except where otherwise noted, data
systemic circulation. Gut microbes degrade the unabsorbed are given for materials in their
choline to trimethylamine, which is oxidized in the liver to standard state (at 25 °C [77 °F],
trimethylamine N-oxide.[6] 100 kPa).
verify (what is ?)
Phosphocholine and glycerophosphocholines are hydrolyzed
via phospholipases to choline, which enters the portal vein. Due Infobox references
to their water solubility, some
of them escape unchanged to
the portal vein. Fat-soluble
choline-containing compounds
(phosphatidylcholines and
sphingomyelins) are either
hydrolyzed by phospholipases Biosynthesis of choline in plants
or enter the lymph
incorporated into
chylomicrons.[6]
Transport
SLC5A7
CTLs: CTL1 (SLC44A1), CTL2 (SLC44A2) and CTL4 (SLC44A4)
OCTs: OCT1 (SLC22A1) and OCT2 (SLC22A2)
SLC5A7s are sodium- (Na+) and ATP-dependent transporters.[16][6] They have high binding affinity for
choline, transport it primarily to neurons and are indirectly associated with the acetylcholine production.[6]
Their deficient function causes hereditary weakness in the pulmonary and other muscles in humans via
acetylcholine deficiency. In knockout mice, their dysfunction results easily in death with cyanosis and
paralysis.[17]
CTL1s have moderate affinity for choline and transport it in almost all tissues, including the intestines, liver,
kidneys, placenta and mitochondria. CTL1s supply choline for phosphatidylcholine and trimethylglycine
production.[6] CTL2s occur especially in the mitochondria in the tongue, kidneys, muscles and heart. They
are associated with the mitochondrial oxidation of choline to trimethylglycine. CTL1s and CTL2s are not
associated with the acetylcholine production, but transport choline together via the blood–brain barrier.
Only CTL2s occur on the brain side of the barrier. They also remove excess choline from the neurons back
to blood. CTL1s occur only on the blood side of the barrier, but also on the membranes of astrocytes and
neurons.[16]
OCT1s and OCT2s are not associated with the acetylcholine production.[6] They transport choline with
low affinity. OCT1s transport choline primarily in the liver and kidneys; OCT2s in kidneys and the
brain.[16]
Storage
Choline is stored in the cell membranes and organelles as phospholipids, and inside cells as
phosphatidylcholines and glycerophosphocholines.[6]
Excretion
Even at choline doses of 2–8 g, little choline is excreted into urine in humans. Excretion happens via
transporters that occur within kidneys (see transport). Trimethylglycine is demethylated in the liver and
kidneys to dimethylglycine (tetrahydrofolate receives one of the methyl groups). Methylglycine forms, is
excreted into urine, or is demethylated to glycine.[6]
Function
Choline and its derivatives have many functions in humans and in other organisms. The most notable
function is that choline serves as a synthetic precursor for other essential cell components and signalling
molecules, such as phospholipids that form cell membranes, the neurotransmitter acetylcholine, and the
osmoregulator trimethylglycine (betaine). Trimethylglycine in turn serves as a source of methyl groups by
participating in the biosynthesis of S-adenosylmethionine.[18][19]
Phospholipid precursor
Choline is transformed to different phospholipids, like phosphatidylcholines and sphingomyelins. These are
found in all cell membranes and the membranes of most cell organelles.[2] Phosphatidylcholines are
structurally important part of the cell membranes. In humans 40–50% of their phospholipids are
phosphatidylcholines.[6]
Choline phospholipids also form lipid rafts in the cell membranes along with cholesterol. The rafts are
centers, for example for receptors and receptor signal transduction enzymes.[2]
Phosphatidylcholines are needed for the synthesis of VLDLs: 70–95% of their phospholipids are
phosphatidylcholines in humans.[6]
Choline is also needed for the synthesis of pulmonary surfactant, which is a mixture consisting mostly of
phosphatidylcholines. The surfactant is responsible for lung elasticity, that is for lung tissue's ability to
contract and expand. For example, deficiency of phosphatidylcholines in the lung tissues has been linked to
acute respiratory distress syndrome.[20]
Phosphatidylcholines are excreted into bile and work together with bile acid salts as surfactants in it, thus
helping with the intestinal absorption of lipids.[2]
Acetylcholine synthesis
Choline is needed to produce acetylcholine. This is a neurotransmitter which plays a necessary role in
muscle contraction, memory and neural development, for example.[6] Nonetheless, there is little
acetylcholine in the human body relative to other forms of choline.[2] Neurons also store choline in the form
of phospholipids to their cell membranes for the production of acetylcholine.[6]
Source of trimethylglycine
In humans, choline is oxidized irreversibly in liver mitochondria to glycine betaine aldehyde by choline
oxidases. This is oxidized by mitochondrial or cytosolic betaine-aldehyde dehydrogenases to
trimethylglycine.[6] Trimethylglycine is a necessary osmoregulator. It also works as a substrate for the
BHMT-enzyme, which methylates homocysteine to methionine. This is a S-adenosylmethionine (SAM)
precursor. SAM is a common reagent in biological methylation reactions. For example, it methylates
guanidines of DNA and certain lysines of histones. Thus it is part of gene expression and epigenetic
regulation. Choline deficiency thus leads to elevated homocysteine levels and decreased SAM levels in
blood.[6]
Content in foods
Choline occurs in foods as a free molecule and in the form of phospholipids, especially as
phosphatidylcholines. Choline is highest in organ meats and egg yolks though it is found to a lesser degree
in non-organ meats, grains, vegetables, fruit and dairy products. Cooking oils and other food fats have
about 5 mg/100 g of total choline.[6] In the United States, food labels express the amount of choline in a
serving as a percentage of daily value (%DV) based on the adequate intake of 550 mg/day. 100% of the
daily value means that a serving of food has 550 mg of choline.[21] "Total choline" is defined as the sum of
free choline and choline-containing phospholipids, without accounting for mass fraction.[22][23][6]
Human breast milk is rich in choline. Exclusive breastfeeding corresponds to about 120 mg of choline per
day for the baby. Increase in a mother's choline intake raises the choline content of breast milk and low
intake decreases it.[6] Infant formulas may or may not contain enough choline. In the EU and the US, it is
mandatory to add at least 7 mg of choline per 100 kilocalories (kcal) to every infant formula. In the EU,
levels above 50 mg/100 kcal are not allowed.[6][24]
Trimethylglycine is a functional metabolite of choline. It substitutes for choline nutritionally, but only
partially.[2] High amounts of trimethylglycine occur in wheat bran (1,339 mg/100 g), toasted wheat germ
(1,240 mg/100 g) and spinach (600–645 mg/100 g), for example.[22]
Choline content of foods (mg/100 g)[a][22]
Meats Vegetables
Bacon, cooked 124.89 Bean, snap 13.46
Beef, trim-cut, cooked 78.15 Beetroot 6.01
Beef liver, pan fried 418.22 Broccoli 40.06
Chicken, roasted, with skin 65.83 Brussels sprout 40.61
Chicken, roasted, no skin 78.74 Cabbage 15.45
Chicken liver 290.03 Carrot 8.79
Cod, atlantic 83.63 Cauliflower 39.10
Ground beef, 75–85% lean, broiled 79.32–82.35 Sweetcorn, yellow 21.95
Pork loin cooked 102.76 Cucumber 5.95
Shrimp, canned 70.60 Lettuce, iceberg 6.70
Dairy products (cow) Lettuce, romaine 9.92
Butter, salted 18.77 Pea 27.51
Cheese 16.50–27.21 Sauerkraut 10.39
Cottage cheese 18.42 Spinach 22.08
Milk, whole/skimmed 14.29–16.40 Sweet potato 13.11
Sour cream 20.33 Tomato 6.74
Yogurt, plain 15.20 Zucchini 9.36
Grains Fruits
Oat bran, raw 58.57 Apple 3.44
Oats, plain 7.42 Avocado 14.18
Rice, white 2.08 Banana 9.76
Rice, brown 9.22 Blueberry 6.04
Wheat bran 74.39 Cantaloupe 7.58
Wheat germ, toasted 152.08 Grape 7.53
Others Grapefruit 5.63
Bean, navy 26.93 Orange 8.38
Egg, hen 251.00 Peach 6.10
Olive oil 0.29 Pear 5.11
Peanut 52.47 Prune 9.66
Soybean, raw 115.87 Strawberry 5.65
Tofu, soft 27.37 Watermelon 4.07
a. Foods are raw unless noted otherwise. Contents are "total choline" as defined above.
Daily values
The following table contains updated sources of choline to reflect the new Daily Value and the new
Nutrition Facts and Supplement Facts Labels.[21] It reflects data from the U.S. Department of Agriculture,
Agricultural Research Service. FoodData Central, 2019.[21]
DV = Daily Value. The U.S. Food and Drug Administration (FDA) developed DVs to help consumers compare the
nutrient contents of foods and dietary supplements within the context of a total diet. The DV for choline is 550 mg for
adults and children age 4 years and older. The FDA does not require food labels to list choline content unless choline
has been added to the food. Foods providing 20% or more of the DV are considered to be high sources of a nutrient,
but foods providing lower percentages of the DV also contribute to a healthful diet. [21]
The U.S. Department of Agriculture's (USDA's) FoodData Central lists the nutrient content of many foods and
provides a comprehensive list of foods containing choline arranged by nutrient content. [21]
Dietary recommendations
Recommendations are in milligrams per day (mg/day). The European Food Safety Authority (EFSA)
recommendations are general recommendations for the EU countries. The EFSA has not set any upper
limits for intake.[6] Individual EU countries may have more specific recommendations. The National
Academy of Medicine (NAM) recommendations apply in the United States,[21] Australia and New
Zealand.[25]
Intake in populations
Twelve surveys undertaken in 9 EU countries between 2000 and 2011 estimated choline intake of adults in
these countries to be 269–468 milligrams per day. Intake was 269–444 mg/day in adult women and 332–
468 mg/day in adult men. Intake was 75–127 mg/day in infants, 151–210 mg/day in 1- to 3-year-olds, 177–
304 mg/day in 3- to 10-year-olds and 244–373 mg/day in 10- to 18-year-olds. The total choline intake
mean estimate was 336 mg/day in pregnant adolescents and 356 mg/day in pregnant women.[6]
A study based on the NHANES 2009–2012 survey estimated the choline intake to be too low in some US
subpopulations. Intake was 315.2–318.8 mg/d in 2+ year olds between this time period. Out of 2+ year
olds, only 15.6 ± 0.8% of males and 6.1 ± 0.6% of females exceeded the adequate intake (AI). AI was
exceeded by 62.9 ± 3.1% of 2- to 3-year-olds, 45.4 ± 1.6% of 4- to 8-year-olds, 9.0 ± 1.0% of 9- to 13-
year-olds, 1.8 ± 0.4% of 14–18 and 6.6 ± 0.5% of 19+ year olds. Upper intake level was not exceeded in
any subpopulations.[26]
A 2013–2014 NHANES study of the US population found the choline intake of 2- to 19-year-olds to be
256 ± 3.8 mg/day and 339 ± 3.9 mg/day in adults 20 and over. Intake was 402 ± 6.1 mg/d in men 20 and
over and 278 mg/d in women 20 and over.[27]
Deficiency
Symptomatic choline deficiency is rare in humans. Most obtain sufficient amounts of it from the diet and
are able to biosynthesize limited amounts of it.[2] Symptomatic deficiency is often caused by certain
diseases or by other indirect causes. Severe deficiency causes muscle damage and non-alcoholic fatty liver
disease, which may develop into cirrhosis.[28]
Besides humans, fatty liver is also a typical sign of choline deficiency in other animals. Bleeding in the
kidneys can also occur in some species. This is suspected to be due to deficiency of choline derived
trimethylglycine, which functions as an osmoregulator.[2]
Estrogen production is a relevant factor which predisposes individuals to deficiency along with low dietary
choline intake. Estrogens activate phosphatidylcholine producing PEMT enzymes. Women before
menopause have lower dietary need for choline than men due to women's higher estrogen production.
Without estrogen therapy, the choline needs of post-menopausal women are similar to men's. Some single-
nucleotide polymorphisms (genetic factors) affecting choline and folate metabolism are also relevant.
Certain gut microbes also degrade choline more efficiently than others, so they are also relevant.[28]
In deficiency, availability of phosphatidylcholines in the liver are decreased – these are needed for
formation of VLDLs. Thus VLDL-mediated fatty acid transport out of the liver decreases leading to fat
accumulation in the liver.[6] Other simultaneously occurring mechanisms explaining the observed liver
damage have also been suggested. For example, choline phospholipids are also needed in mitochondrial
membranes. Their inavailability leads to the inability of mitochondrial membranes to maintain proper
electrochemical gradient, which, among other things, is needed for degrading fatty acids via β-oxidation.
Fat metabolism within liver therefore decreases.[28]
Excess intake
Excessive doses of choline can have adverse effects. Daily 8–20 g doses of choline, for example, have
been found to cause low blood pressure, nausea, diarrhea and fish-like body odor. The odor is due to
trimethylamine (TMA) formed by the gut microbes from the unabsorbed choline (see trimethylaminuria).[6]
The liver oxidizes TMA to trimethylamine N-oxide (TMAO). Elevated levels of TMA and TMAO in the
body have been linked to increased risk of atherosclerosis and mortality. Thus, excessive choline intake has
been hypothetized to increase these risks in addition to carnitine, which also is formed into TMA and
TMAO by gut bacteria. However, choline intake has not been shown to increase the risk of dying from
cardiovascular diseases.[29] It is plausible that elevated TMA and TMAO levels are just a symptom of other
underlying illnesses or genetic factors that predispose individuals for increased mortality. Such factors may
have not been properly accounted for in certain studies observing TMA and TMAO level related mortality.
Causality may be reverse or confounding and large choline intake might not increase mortality in humans.
For example, kidney dysfunction predisposes for cardiovascular diseases, but can also decrease TMA and
TMAO excretion.[30]
Health effects
Some human studies showed low maternal intake of choline to significantly increase the risk of neural tube
defects (NTDs) in newborns.[4] Folate deficiency also causes NTDs. Choline and folate, interacting with
vitamin B12 , act as methyl donors to homocysteine to form methionine, which can then go on to form SAM
(S-adenosylmethionine).[4] SAM is the substrate for almost all methylation reactions in mammals. It has
been suggested that disturbed methylation via SAM could be responsible for the relation between folate and
NTDs.[31] This may also apply to choline. Certain mutations that disturb choline metabolism increase the
prevalence of NTDs in newborns, but the role of dietary choline deficiency remains unclear, as of 2015.[4]
Choline deficiency can cause fatty liver, which increases cancer and cardiovascular disease risk. Choline
deficiency also decreases SAM production, which partakes in DNA methylation – this decrease may also
contribute to carcinogenesis. Thus, deficiency and its association with such diseases has been studied.[6]
However, observational studies of free populations have not convincingly shown an association between
low choline intake and cardiovascular diseases or most cancers.[4][6] Studies on prostate cancer have been
contradictory.[32][33]
Cognition
Studies observing the effect between higher choline intake and cognition have been conducted in human
adults, with contradictory results.[4][34] Similar studies on human infants and children have been
contradictory and also limited.[4]
Perinatal development
Both pregnancy and lactation increase demand for choline dramatically. This demand may be met by
upregulation of PEMT via increasing estrogen levels to produce more choline de novo, but even with
increased PEMT activity, the demand for choline is still so high that bodily stores are generally depleted.
This is exemplified by the observation that Pemt −/− mice (mice lacking functional PEMT) will abort at 9–
10 days unless fed supplemental choline.[35]
While maternal stores of choline are depleted during pregnancy and lactation, the placenta accumulates
choline by pumping choline against the concentration gradient into the tissue, where it is then stored in
various forms, mostly as acetylcholine. Choline concentrations in amniotic fluid can be ten times higher
than in maternal blood.[35]
Choline is in high demand during pregnancy as a substrate for building cellular membranes (rapid fetal and
mother tissue expansion), increased need for one-carbon moieties (a substrate for methylation of DNA and
other functions), raising choline stores in fetal and placental tissues, and for increased production of
lipoproteins (proteins containing "fat" portions).[36][37][38] In particular, there is interest in the impact of
choline consumption on the brain. This stems from choline's use as a material for making cellular
membranes (particularly in making phosphatidylcholine). Human brain growth is most rapid during the
third trimester of pregnancy and continues to be rapid to approximately five years of age.[39] During this
time, the demand is high for sphingomyelin, which is made from phosphatidylcholine (and thus from
choline), because this material is used to myelinate (insulate) nerve fibers.[40] Choline is also in demand for
the production of the neurotransmitter acetylcholine, which can influence the structure and organization of
brain regions, neurogenesis, myelination, and synapse formation. Acetylcholine is even present in the
placenta and may help control cell proliferation and differentiation (increases in cell number and changes of
multiuse cells into dedicated cellular functions) and parturition.[41][42]
Choline uptake into the brain is controlled by a low-affinity transporter located at the blood–brain
barrier.[43] Transport occurs when arterial plasma choline concentrations increase above 14 μmol/L, which
can occur during a spike in choline concentration after consuming choline-rich foods. Neurons, conversely,
acquire choline by both high- and low-affinity transporters. Choline is stored as membrane-bound
phosphatidylcholine, which can then be used for acetylcholine neurotransmitter synthesis later.
Acetylcholine is formed as needed, travels across the synapse, and transmits the signal to the following
neuron. Afterwards, acetylcholinesterase degrades it, and the free choline is taken up by a high-affinity
transporter into the neuron again.[44]
Uses
Choline chloride and choline bitartrate are used in dietary supplements. Bitartrate is used more often due to
its lower hygroscopicity.[2] Certain choline salts are used to supplement chicken, turkey and some other
animal feeds. Some salts are also used as industrial chemicals: for example, in photolithography to remove
photoresist.[1] Choline theophyllinate and choline salicylate are used as medicines,[1][45] as well as
structural analogs, like methacholine and carbachol.[46] Radiolabeled cholines, like 11 C-choline, are used in
medical imaging.[47] Other commercially used salts include tricholine citrate and choline bicarbonate.[1]
History
Discovery
In 1849, Adolph Strecker was the first to isolate choline from pig bile.[48][49] In 1852, L. Babo and M.
Hirschbrunn extracted choline from white mustard seeds and named it sinkaline.[49] In 1862, Strecker
repeated his experiment with pig and ox bile, calling the substance choline for the first time after the Greek
word for bile, chole, and identifying it with the chemical formula C5 H13 NO.[50][15] In 1850, Theodore
Nicolas Gobley extracted from the brains and roe of carps a substance he named lecithin after the Greek
word for egg yolk, lekithos, showing in 1874 that it was a mixture of phosphatidylcholines.[51][52]
In 1865, Oscar Liebreich isolated "neurine" from animal brains.[53][15] The structural formulas of
acetylcholine and Liebreich's "neurine" were resolved by Adolf von Baeyer in 1867.[54][49] Later that year
"neurine" and sinkaline were shown to be the same substances as Strecker's choline. Thus, Bayer was the
first to resolve the structure of choline.[55][56][49] The compound now known as neurine is unrelated to
choline.[15]
Discovery as a nutrient
In the early 1930s, Charles Best and colleagues noted that fatty liver in rats on a special diet and diabetic
dogs could be prevented by feeding them lecithin,[15] proving in 1932 that choline in lecithin was solely
responsible for this preventive effect.[57] In 1998, the US National Academy of Medicine reported their
first recommendations for choline in the human diet.[58]
References
1. Kirk RE, et al. (2000). Kirk-Othmer encyclopedia of chemical technology. Vol. 6 (4th ed.).
John Wiley & Sons. pp. 100–102. ISBN 9780471484943.
2. Rucker RB, Zempleni J, Suttie JW, McCormick DB (2007). Handbook of vitamins (https://arc
hive.org/details/handbookvitamins00jzem) (4th ed.). Taylor & Francis. pp. 459 (https://archiv
e.org/details/handbookvitamins00jzem/page/n471)–477. ISBN 9780849340222.
3. "Choline" (https://web.archive.org/web/20191024155716/https://www.lexico.com/en/definitio
n/choline). Lexico Dictionaries. Archived from the original (https://www.lexico.com/en/definiti
on/choline) on 24 October 2019. Retrieved 9 November 2019.
4. "Choline" (http://lpi.oregonstate.edu/mic/other-nutrients/choline). Micronutrient Information
Center, Linus Pauling Institute, Oregon State University. February 2015. Retrieved
11 November 2019.
5. "Choline" (http://www.hmdb.ca/metabolites/hmdb00097). Human Metabolome Database.
The Metabolomics Innovation Centre, University of Alberta, Edmonton, Canada. 17 August
2016. Retrieved 13 September 2016.
6. "Dietary reference values for choline" (https://doi.org/10.2903%2Fj.efsa.2016.4484). EFSA
Journal. 14 (8). 2016. doi:10.2903/j.efsa.2016.4484 (https://doi.org/10.2903%2Fj.efsa.2016.4
484). "In this Opinion, the Panel considers dietary choline including choline compounds
(e.g. glycerophosphocholine, phosphocholine, phosphatidylcholine, sphingomyelin)."
7. "Office of Dietary Supplements - Choline" (https://ods.od.nih.gov/factsheets/Choline-HealthP
rofessional/).
8. Britannica, The Editors of Encyclopaedia. "choline". Encyclopedia Britannica, 11 Dec. 2013,
https://www.britannica.com/science/choline. Accessed 17 February 2022.
9. National Center for Biotechnology Information (2022). PubChem Compound Summary for
CID 305, Choline. Retrieved February 17, 2022 from
https://pubchem.ncbi.nlm.nih.gov/compound/Choline.
10. Rontein D, Nishida I, Tashiro G, Yoshioka K, Wu WI, Voelker DR, Basset G, Hanson AD
(September 2001). "Plants synthesize ethanolamine by direct decarboxylation of serine
using a pyridoxal phosphate enzyme" (https://doi.org/10.1074%2Fjbc.M106038200). The
Journal of Biological Chemistry. 276 (38): 35523–9. doi:10.1074/jbc.M106038200 (https://do
i.org/10.1074%2Fjbc.M106038200). PMID 11461929 (https://pubmed.ncbi.nlm.nih.gov/1146
1929).
11. Prud'homme MP, Moore TS (November 1992). "Phosphatidylcholine synthesis in castor
bean endosperm : free bases as intermediates" (https://www.ncbi.nlm.nih.gov/pmc/articles/P
MC1075815). Plant Physiology. 100 (3): 1527–35. doi:10.1104/pp.100.3.1527 (https://doi.or
g/10.1104%2Fpp.100.3.1527). PMC 1075815 (https://www.ncbi.nlm.nih.gov/pmc/articles/PM
C1075815). PMID 16653153 (https://pubmed.ncbi.nlm.nih.gov/16653153).
12. Nuccio ML, Ziemak MJ, Henry SA, Weretilnyk EA, Hanson AD (May 2000). "cDNA cloning
of phosphoethanolamine N-methyltransferase from spinach by complementation in
Schizosaccharomyces pombe and characterization of the recombinant enzyme" (https://doi.
org/10.1074%2Fjbc.275.19.14095). The Journal of Biological Chemistry. 275 (19): 14095–
101. doi:10.1074/jbc.275.19.14095 (https://doi.org/10.1074%2Fjbc.275.19.14095).
PMID 10799484 (https://pubmed.ncbi.nlm.nih.gov/10799484).
13. McNeil SD, Nuccio ML, Ziemak MJ, Hanson AD (August 2001). "Enhanced synthesis of
choline and glycine betaine in transgenic tobacco plants that overexpress
phosphoethanolamine N-methyltransferase" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC
55567). Proceedings of the National Academy of Sciences of the United States of America.
98 (17): 10001–5. Bibcode:2001PNAS...9810001M (https://ui.adsabs.harvard.edu/abs/2001
PNAS...9810001M). doi:10.1073/pnas.171228998 (https://doi.org/10.1073%2Fpnas.171228
998). PMC 55567 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55567). PMID 11481443
(https://pubmed.ncbi.nlm.nih.gov/11481443).
14. "Superpathway of choline biosynthesis" (https://biocyc.org/META/NEW-IMAGE?object=PW
Y-4762). BioCyc Database Collection: MetaCyc. SRI International.
15. Zeisel SH (2012). "A brief history of choline" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC
4422379). Annals of Nutrition & Metabolism. 61 (3): 254–8. doi:10.1159/000343120 (https://d
oi.org/10.1159%2F000343120). PMC 4422379 (https://www.ncbi.nlm.nih.gov/pmc/articles/P
MC4422379). PMID 23183298 (https://pubmed.ncbi.nlm.nih.gov/23183298).
16. Inazu M (September 2019). "Functional Expression of Choline Transporters in the Blood-
Brain Barrier" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835570). Nutrients. 11 (10):
2265. doi:10.3390/nu11102265 (https://doi.org/10.3390%2Fnu11102265). PMC 6835570 (ht
tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835570). PMID 31547050 (https://pubmed.nc
bi.nlm.nih.gov/31547050).
17. Barwick KE, Wright J, Al-Turki S, McEntagart MM, Nair A, Chioza B, et al. (December 2012).
"Defective presynaptic choline transport underlies hereditary motor neuropathy" (https://ww
w.ncbi.nlm.nih.gov/pmc/articles/PMC3516609). American Journal of Human Genetics. 91
(6): 1103–7. doi:10.1016/j.ajhg.2012.09.019 (https://doi.org/10.1016%2Fj.ajhg.2012.09.019).
PMC 3516609 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516609). PMID 23141292
(https://pubmed.ncbi.nlm.nih.gov/23141292).
18. Glier MB, Green TJ, Devlin AM (January 2014). "Methyl nutrients, DNA methylation, and
cardiovascular disease". Molecular Nutrition & Food Research. 58 (1): 172–82.
doi:10.1002/mnfr.201200636 (https://doi.org/10.1002%2Fmnfr.201200636). PMID 23661599
(https://pubmed.ncbi.nlm.nih.gov/23661599).
19. Barak AJ, Beckenhauer HC, Junnila M, Tuma DJ (June 1993). "Dietary betaine promotes
generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty
infiltration". Alcoholism: Clinical and Experimental Research. 17 (3): 552–5.
doi:10.1111/j.1530-0277.1993.tb00798.x (https://doi.org/10.1111%2Fj.1530-0277.1993.tb00
798.x). PMID 8333583 (https://pubmed.ncbi.nlm.nih.gov/8333583).
20. Dushianthan A, Cusack R, Grocott MP, Postle AD (June 2018). "Abnormal liver
phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome"
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983399). Journal of Lipid Research. 59 (6):
1034–1045. doi:10.1194/jlr.P085050 (https://doi.org/10.1194%2Fjlr.P085050).
PMC 5983399 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983399). PMID 29716960
(https://pubmed.ncbi.nlm.nih.gov/29716960).
21. "Choline" (https://ods.od.nih.gov/factsheets/Choline-HealthProfessional/). Office of Dietary
Supplements (ODS) at the National Institutes of Health. Retrieved 19 May 2020. This
article incorporates text from this source, which is in the public domain.
22. Zeisel SH, Mar MH, Howe JC, Holden JM (May 2003). "Concentrations of choline-
containing compounds and betaine in common foods" (https://www.researchgate.net/publica
tion/10775683). The Journal of Nutrition. 133 (5): 1302–7. doi:10.1093/jn/133.5.1302 (https://
doi.org/10.1093%2Fjn%2F133.5.1302). PMID 12730414 (https://pubmed.ncbi.nlm.nih.gov/1
2730414).
23. "USDA Database for the Choline Content of Common Foods, Release 2" (https://data.nal.us
da.gov/dataset/usda-database-choline-content-common-foods-release-2-2008). USDA Ag
Data Commons. January 2008. "Total choline content was calculated as the sum of Cho,
GPC, Pcho, Ptdcho, and SM."
24. "21 CFR 107.100: Infant formula; Nutrient requirements; Nutrient specifications; Choline
content" (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=107.10
0). Code of Federal Regulations, Title 21; Food and Drug Administration. 1 April 2019.
Retrieved 24 October 2019.
25. Choline (17 March 2014). "Choline" (https://www.nrv.gov.au/nutrients/choline).
www.nrv.gov.au. Retrieved 22 October 2019.
26. Wallace TC, Fulgoni VL (2016). "Assessment of Total Choline Intakes in the United States".
Journal of the American College of Nutrition. 35 (2): 108–12.
doi:10.1080/07315724.2015.1080127
(https://doi.org/10.1080%2F07315724.2015.1080127). PMID 26886842 (https://pubmed.ncb
i.nlm.nih.gov/26886842). S2CID 24063121 (https://api.semanticscholar.org/CorpusID:24063
121).
27. "What We Eat in America, NHANES 2013-2014" (https://www.ars.usda.gov/ARSUserFiles/8
0400530/pdf/1314/Table_1_NIN_GEN_13.pdf) (PDF). Retrieved 24 October 2019.
28. Corbin KD, Zeisel SH (March 2012). "Choline metabolism provides novel insights into
nonalcoholic fatty liver disease and its progression" (https://www.ncbi.nlm.nih.gov/pmc/articl
es/PMC3601486). Current Opinion in Gastroenterology. 28 (2): 159–65.
doi:10.1097/MOG.0b013e32834e7b4b (https://doi.org/10.1097%2FMOG.0b013e32834e7b4
b). PMC 3601486 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601486).
PMID 22134222 (https://pubmed.ncbi.nlm.nih.gov/22134222).
29. DiNicolantonio JJ, McCarty M, OKeefe J (2019). "Association of moderately elevated
trimethylamine N-oxide with cardiovascular risk: is TMAO serving as a marker for hepatic
insulin resistance" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443140). Open Heart. 6
(1): e000890. doi:10.1136/openhrt-2018-000890 (https://doi.org/10.1136%2Fopenhrt-2018-0
00890). PMC 6443140 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443140).
PMID 30997120 (https://pubmed.ncbi.nlm.nih.gov/30997120).
30. Jia J, Dou P, Gao M, Kong X, Li C, Liu Z, Huang T (September 2019). "Assessment of
Causal Direction Between Gut Microbiota-Dependent Metabolites and Cardiometabolic
Health: A Bidirectional Mendelian Randomization Analysis" (https://doi.org/10.2337%2Fdb1
9-0153). Diabetes. 68 (9): 1747–1755. doi:10.2337/db19-0153 (https://doi.org/10.2337%2Fd
b19-0153). PMID 31167879 (https://pubmed.ncbi.nlm.nih.gov/31167879).
31. Imbard A, et al. (2013). "Neural tube defects, folic acid and methylation" (https://www.ncbi.nl
m.nih.gov/pmc/articles/PMC3799525). International Journal of Environmental Research and
Public Health. 10 (9): 4352–4389. doi:10.3390/ijerph10094352 (https://doi.org/10.3390%2Fij
erph10094352). PMC 3799525 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799525).
PMID 24048206 (https://pubmed.ncbi.nlm.nih.gov/24048206).
32. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Zeisel SH, Willett WC, Chan JM
(October 2012). "Choline intake and risk of lethal prostate cancer: incidence and survival" (ht
tps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441112). The American Journal of Clinical
Nutrition. 96 (4): 855–63. doi:10.3945/ajcn.112.039784 (https://doi.org/10.3945%2Fajcn.112.
039784). PMC 3441112 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441112).
PMID 22952174 (https://pubmed.ncbi.nlm.nih.gov/22952174).
33. Han P, Bidulescu A, Barber JR, Zeisel SH, Joshu CE, Prizment AE, et al. (April 2019).
"Dietary choline and betaine intakes and risk of total and lethal prostate cancer in the
Atherosclerosis Risk in Communities (ARIC) Study" (https://www.ncbi.nlm.nih.gov/pmc/articl
es/PMC6553878). Cancer Causes & Control. 30 (4): 343–354. doi:10.1007/s10552-019-
01148-4 (https://doi.org/10.1007%2Fs10552-019-01148-4). PMC 6553878 (https://www.ncbi.
nlm.nih.gov/pmc/articles/PMC6553878). PMID 30825046 (https://pubmed.ncbi.nlm.nih.gov/3
0825046).
34. Wiedeman AM, Barr SI, Green TJ, Xu Z, Innis SM, Kitts DD (October 2018). "Dietary Choline
Intake: Current State of Knowledge Across the Life Cycle" (https://www.ncbi.nlm.nih.gov/pm
c/articles/PMC6213596). Nutrients. 10 (10): 1513. doi:10.3390/nu10101513 (https://doi.org/1
0.3390%2Fnu10101513). PMC 6213596 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC62
13596). PMID 30332744 (https://pubmed.ncbi.nlm.nih.gov/30332744).
35. Zeisel SH (2006). "Choline: critical role during fetal development and dietary requirements
in adults" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441939). Annual Review of
Nutrition. 26: 229–50. doi:10.1146/annurev.nutr.26.061505.111156 (https://doi.org/10.1146%
2Fannurev.nutr.26.061505.111156). PMC 2441939 (https://www.ncbi.nlm.nih.gov/pmc/article
s/PMC2441939). PMID 16848706 (https://pubmed.ncbi.nlm.nih.gov/16848706).
36. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for Thiamine,
Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline.
Washington, DC: National Academies Press. 1998.
37. Allen LH (2006). "Pregnancy and lactation". In Bowman BA, Russle RM (eds.). Present
Knowledge in Nutrition. Washington DC: ILSI Press. pp. 529–543.
38. King JC (May 2000). "Physiology of pregnancy and nutrient metabolism" (https://doi.org/10.1
093%2Fajcn%2F71.5.1218s). The American Journal of Clinical Nutrition. 71 (5 Suppl):
1218S–25S. doi:10.1093/ajcn/71.5.1218s (https://doi.org/10.1093%2Fajcn%2F71.5.1218s).
PMID 10799394 (https://pubmed.ncbi.nlm.nih.gov/10799394).
39. Morgane PJ, Mokler DJ, Galler JR (June 2002). "Effects of prenatal protein malnutrition on
the hippocampal formation". Neuroscience and Biobehavioral Reviews. 26 (4): 471–83.
doi:10.1016/s0149-7634(02)00012-x (https://doi.org/10.1016%2Fs0149-7634%2802%2900
012-x). PMID 12204193 (https://pubmed.ncbi.nlm.nih.gov/12204193). S2CID 7051841 (http
s://api.semanticscholar.org/CorpusID:7051841).
40. Oshida K, Shimizu T, Takase M, Tamura Y, Shimizu T, Yamashiro Y (April 2003). "Effects of
dietary sphingomyelin on central nervous system myelination in developing rats" (https://doi.
org/10.1203%2F01.pdr.0000054654.73826.ac). Pediatric Research. 53 (4): 589–93.
doi:10.1203/01.pdr.0000054654.73826.ac (https://doi.org/10.1203%2F01.pdr.0000054654.7
3826.ac). PMID 12612207 (https://pubmed.ncbi.nlm.nih.gov/12612207).
41. Sastry BV (June 1997). "Human placental cholinergic system". Biochemical Pharmacology.
53 (11): 1577–86. doi:10.1016/s0006-2952(97)00017-8 (https://doi.org/10.1016%2Fs0006-2
952%2897%2900017-8). PMID 9264309 (https://pubmed.ncbi.nlm.nih.gov/9264309).
42. Sastry BV, Sadavongvivad C (March 1978). "Cholinergic systems in non-nervous tissues".
Pharmacological Reviews. 30 (1): 65–132. PMID 377313 (https://pubmed.ncbi.nlm.nih.gov/3
77313).
43. Lockman PR, Allen DD (August 2002). "The transport of choline". Drug Development and
Industrial Pharmacy. 28 (7): 749–71. doi:10.1081/DDC-120005622 (https://doi.org/10.1081%
2FDDC-120005622). PMID 12236062 (https://pubmed.ncbi.nlm.nih.gov/12236062).
S2CID 34402785 (https://api.semanticscholar.org/CorpusID:34402785).
44. Caudill MA (August 2010). "Pre- and postnatal health: evidence of increased choline
needs". Journal of the American Dietetic Association. 110 (8): 1198–206.
doi:10.1016/j.jada.2010.05.009 (https://doi.org/10.1016%2Fj.jada.2010.05.009).
PMID 20656095 (https://pubmed.ncbi.nlm.nih.gov/20656095).
45. Rutter P (2017). Community pharmacy: symptoms, diagnosis, and treatment (4th ed.).
Elsevier. p. 156. ISBN 9780702069970.
46. Howe-Grant M, Kirk RE, Othmer DF, eds. (2000). "C2-Chlorocarbons to Combustion
Technology". Kirk-Othmer encyclopedia of chemical technology. Vol. 6 (4th ed.). John Wiley
& Sons. pp. 100–102. ISBN 9780471484943.
47. Guo Y, Wang L, Hu J, Feng D, Xu L (2018). "Diagnostic performance of choline PET/CT for
the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis"
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128558). PLOS ONE. 13 (9): e0203400.
Bibcode:2018PLoSO..1303400G (https://ui.adsabs.harvard.edu/abs/2018PLoSO..1303400
G). doi:10.1371/journal.pone.0203400 (https://doi.org/10.1371%2Fjournal.pone.0203400).
PMC 6128558 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128558). PMID 30192819
(https://pubmed.ncbi.nlm.nih.gov/30192819).
48. Strecker A (1849). "Beobachtungen über die galle verschiedener thiere" (https://zenodo.org/r
ecord/1427022). Justus Liebigs Ann Chem (in German). 70 (2): 149–197.
doi:10.1002/jlac.18490700203 (https://doi.org/10.1002%2Fjlac.18490700203).
49. Sebrell WH, Harris RS, Alam SQ (1971). The vitamins. Vol. 3 (2nd ed.). Academic Press.
pp. 4, 12. doi:10.1016/B978-0-12-633763-1.50007-5 (https://doi.org/10.1016%2FB978-0-12-
633763-1.50007-5). ISBN 9780126337631.
50. Strecker A (1862). "Üeber einige neue bestandtheile der schweinegalle" (https://zenodo.org/
record/1427185). Justus Liebigs Ann Chem (in German). 123 (3): 353–360.
doi:10.1002/jlac.18621230310 (https://doi.org/10.1002%2Fjlac.18621230310).
51. Gobley T (1874). "Sur la lécithine et la cérébrine" (https://archive.org/details/journaldepharm
a26parigoog). J Pharm Chim (in French). 19 (4): 346 (https://archive.org/details/journaldeph
arma26parigoog/page/n352)–354.
52. Sourkes TL (2004). "The discovery of lecithin, the first phospholipid" (http://acshist.scs.illinoi
s.edu/bulletin_open_access/v29-1/v29-1%20p9-15.pdf) (PDF). Bull Hist Chem. 29 (1): 9–15.
Archived (https://web.archive.org/web/20190413044150/http://acshist.scs.illinois.edu/bulleti
n_open_access/v29-1/v29-1%20p9-15.pdf) (PDF) from the original on 13 April 2019.
53. Liebreich O (1865). "Üeber die chemische beschaffenheit der gehirnsubstanz" (https://zenod
o.org/record/1769614). Justus Liebigs Ann Chem (in German). 134 (1): 29–44.
doi:10.1002/jlac.18651340107 (https://doi.org/10.1002%2Fjlac.18651340107).
S2CID 97165871 (https://api.semanticscholar.org/CorpusID:97165871).
54. Baeyer A (1867). "I. Üeber das neurin" (https://zenodo.org/record/2483316). Justus Liebigs
Ann Chem (in German). 142 (3): 322–326. doi:10.1002/jlac.18671420311 (https://doi.org/10.
1002%2Fjlac.18671420311).
55. Dybkowsky W (1867). "Üeber die identität des cholins und des neurins" (https://zenodo.org/r
ecord/1850615) [On the identity of choline & neurin]. J Prakt Chem (in German). 100 (1):
153–164. doi:10.1002/prac.18671000126 (https://doi.org/10.1002%2Fprac.18671000126).
56. Claus A, Keesé C (1867). "Üeber neurin und sinkalin" (https://zenodo.org/record/2464361).
J Prakt Chem (in German). 102 (1): 24–27. doi:10.1002/prac.18671020104 (https://doi.org/1
0.1002%2Fprac.18671020104).
57. Best CH, Hershey JM, Huntsman ME (May 1932). "The effect of lecithine on fat deposition in
the liver of the normal rat" (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1394511). The
Journal of Physiology. 75 (1): 56–66. doi:10.1113/jphysiol.1932.sp002875 (https://doi.org/10.
1113%2Fjphysiol.1932.sp002875). PMC 1394511 (https://www.ncbi.nlm.nih.gov/pmc/article
s/PMC1394511). PMID 16994301 (https://pubmed.ncbi.nlm.nih.gov/16994301).
58. Institute of Medicine (US) Standing Committee on the scientific evaluation of dietary
reference intakes and its panel on folate, other B. vitamins, and choline (https://www.ncbi.nl
m.nih.gov/books/NBK114308/). National Academies Press (US). 1998. pp. xi, 402–413.
ISBN 9780309064118.